Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CASP2 | P42575 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.49 |
| ▸ | FAAH | O00519 | 3/20 | 0.46 |
| ▸ | MMP9 | P14780 | 1/20 | 0.46 |
| ▸ | MMP8 | P22894 | 1/20 | 0.46 |
| ▸ | MMP14 | P50281 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29000004 | 0.86 | CASP2 (0.67) | CASP2NAAAFAAHDNM1 | |
| SCHEMBL23375898 | 0.85 | CA2 (0.50) | CA2CASP2NAAAFAAHMMP9 | |
| SCHEMBL22919269 | 0.83 | FAAH (0.56) | CA2CASP2NAAAFAAHCNR1 | |
| SCHEMBL25098583 | 0.82 | MEN1 (0.61) | CA2CASP2NAAAFAAHMMP9 | |
| SCHEMBL18513342 | 0.82 | CASP2 (0.67) | CASP2NAAAFAAHDNM1 | |
| SCHEMBL25776576 | 0.82 | CASP2 (0.67) | CASP2NAAAFAAHDNM1 | |
| SCHEMBL20756589 | 0.81 | FAAH (0.58) | CASP2NAAAFAAHCNR1DNM1 | |
| SCHEMBL23480269 | 0.81 | FAAH (0.49) | CA2CASP2NAAAFAAHCNR1 | |
| SCHEMBL29031786 | 0.81 | FAAH (0.61) | CA2CASP2NAAAFAAHDNM1 | |
| SCHEMBL24701170 | 0.81 | NAAA (0.47) | CASP2NAAAFAAHCNR1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018125-B2 | Block-copolymers for the delivery of active agents | JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG (DE) | 2024-06-25 | — | — | US | disclosed |
| US-20210147627-A1 | BLOCK-COPOLYMERS FOR THE DELIVERY OF ACTIVE AGENTS | JULIUS-MAXIMILIANS-UNIVERSITÄT WÜRZBURG (DE) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147627-A1 | BLOCK-COPOLYMERS FOR THE DELIVERY OF ACTIVE AGENTS | NR0B1, NR0B2, OGFR | CA2 2851/4885CASP2 4665/4885NAAA 4157/4885 |
| US-12018125-B2 | Block-copolymers for the delivery of active agents | NR0B1, NR0B2, OGFR | CA2 2851/4885CASP2 4665/4885NAAA 4157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.